Three-Year Follow-Up of the POIBA Intervention on Childhood Obesity: A Quasi-Experimental Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
29 Jan 2021
Historique:
received: 12 12 2020
revised: 25 01 2021
accepted: 26 01 2021
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 6 5 2021
Statut: epublish

Résumé

Childhood obesity has increased worldwide over the past four decades. This quasi-experimental study aimed to assess the effectiveness of a multicomponent and multilevel school-based intervention (POIBA) at 3 years of follow-up. The nutrition intervention focused on food groups, food pyramid, nutrients, portions, and balanced menus. In total, 3624 children participated in the study. Anthropometric measurements and information on food frequency and behavior, physical activity, and daily screen use were collected in the intervention (IG) and comparison group (CG). Positive unadjusted changes toward adherence to recommendations were found for water, meat, sweets, and fried potato consumption, proper breakfast, not having dinner in front of the TV, out-of-school physical activity, and daily screen use. Three scores were used to calculate the proportion of children making more than one change to improve healthy habits regarding physical activity (global Activity score), nutrition (global Nutrition score), and both (global score). Students exposed to the intervention had a significantly better global Activity score (16.2% IG vs. 11.9% CG;

Identifiants

pubmed: 33573017
pii: nu13020453
doi: 10.3390/nu13020453
pmc: PMC7911572
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI09/02259

Références

Obes Rev. 2020 Jun;21(6):e13001
pubmed: 32162477
Health Educ Res. 2005 Jun;20(3):308-13
pubmed: 15522898
Cochrane Database Syst Rev. 2018 Mar 02;3:CD009728
pubmed: 29499084
Am J Clin Nutr. 2007 Jun;85(6):1533-9
pubmed: 17556689
Food Nutr Res. 2017 Oct 30;61(1):1391665
pubmed: 29151829
Nutr Hosp. 2016 Dec 07;33(Suppl 8):1-48
pubmed: 28286959
Obes Rev. 2015 Jul;16(7):547-65
pubmed: 25893796
Pediatr Exerc Sci. 2013 Nov;25(4):573-90
pubmed: 24214440
Soc Sci Med. 2008 Mar;66(6):1429-36
pubmed: 18179852
J Sch Health. 2017 Nov;87(11):873-881
pubmed: 29023836
Future Child. 2006 Spring;16(1):109-42
pubmed: 16532661
BMC Public Health. 2016 Mar 01;16:205
pubmed: 26931236
Int J Obes (Lond). 2013 Jan;37(1):47-53
pubmed: 22158265
Lancet Diabetes Endocrinol. 2018 Apr;6(4):332-346
pubmed: 29066096
J Am Diet Assoc. 2004 May;104(5):746-52
pubmed: 15127059
Eur Eat Disord Rev. 2009 Jul;17(4):315-23
pubmed: 19452495
Vital Health Stat 11. 2012 Oct;(252):1-48
pubmed: 25204692
J Acad Nutr Diet. 2013 Oct;113(10):1375-94
pubmed: 24054714
BMC Endocr Disord. 2020 May 6;20(Suppl 2):52
pubmed: 32370795
Int J Prev Med. 2017 Sep 19;8:73
pubmed: 29026505
Am J Prev Med. 2003 Apr;24(3):209-17
pubmed: 12657338
Int J Prev Med. 2015 Aug 03;6:68
pubmed: 26330984
Eur J Pediatr. 2015 Jun;174(6):715-46
pubmed: 25922141
Endocrinol Nutr. 2012 May;59(5):288-95
pubmed: 22521298
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Am J Med. 2013 Oct;126(10):903-8
pubmed: 23932159
Appetite. 2008 Jul;51(1):187-93
pubmed: 18375017
Pediatrics. 2005 Feb;115(2):333-9
pubmed: 15687441
Obes Facts. 2011;4(1):35-43
pubmed: 21372609
Int J Environ Res Public Health. 2012 Apr;9(4):1438-57
pubmed: 22690204
Clin Nutr. 2019 Dec;38(6):2592-2598
pubmed: 30737048
Int J Behav Nutr Phys Act. 2019 Oct 29;16(1):95
pubmed: 31665040
J Nutr. 2019 Feb 1;149(2):258-269
pubmed: 30753540
J Public Health Res. 2018 Feb 05;7(1):1129
pubmed: 29780761
Drug Alcohol Depend. 2013 Sep 1;132(1-2):257-64
pubmed: 23490453
Nutrients. 2018 Jul 17;10(7):
pubmed: 30018221
Medicina (Kaunas). 2020 Apr 09;56(4):
pubmed: 32283681
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
J Sch Health. 2008 Apr;78(4):189-96
pubmed: 18336677
Int J Obes (Lond). 2017 Jul;41(7):1027-1034
pubmed: 28216643

Auteurs

Francesca Sánchez-Martínez (F)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIIB Sant Pau), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
Pompeu Fabra University (UPF), Health and Experimental Science Department, Doctor Aiguader 80, 08003 Barcelona, Spain.

Silvia Brugueras (S)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.

Gemma Serral (G)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIIB Sant Pau), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
Ciber de Epidemiología y Salud Pública (CIBERESP), Monforte de Lemos 3-5, 28029 Madrid, Spain.

Sara Valmayor (S)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.

Olga Juárez (O)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.

María José López (MJ)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIIB Sant Pau), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
Pompeu Fabra University (UPF), Health and Experimental Science Department, Doctor Aiguader 80, 08003 Barcelona, Spain.
Ciber de Epidemiología y Salud Pública (CIBERESP), Monforte de Lemos 3-5, 28029 Madrid, Spain.

Carles Ariza (C)

Agència de Salut Pública de Barcelona (Public Health Agency of Barcelona, ASPB), Pl Lesseps 1, 08023 Barcelona, Spain.
Institut d'Investigació Biomèdica Sant Pau (IIIB Sant Pau), Sant Antoni Maria Claret 167, 08025 Barcelona, Spain.
Ciber de Epidemiología y Salud Pública (CIBERESP), Monforte de Lemos 3-5, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH